BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2025 7:47:21 AM | Browse: 74 | Download: 153
 |
Received |
|
2025-01-11 05:45 |
|
Peer-Review Started |
|
2025-01-11 05:45 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-03-11 21:25 |
|
Revised |
|
2025-04-27 04:29 |
|
Second Decision |
|
2025-07-02 02:36 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-07-02 06:33 |
|
Articles in Press |
|
2025-07-02 06:33 |
|
Publication Fee Transferred |
|
2025-04-29 02:10 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-07-22 03:37 |
|
Publish the Manuscript Online |
|
2025-07-24 07:47 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lei Ma, Meng-Han Zhang, Yi-Fan Xu, Yan-Xu Hao, Xuan-Xuan Niu, Yan Li and Hui-Chun Xing |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Key R&D Program of China |
2022YFC2304500 and 2021YFC2301801 |
| Beijing Municipal of Science and Technology Major Project |
Z221100007422002 |
| Capital Funds for Health Improvement and Research |
CFH-2024-1-2181 |
| Beijing Igandan Foundation |
iGandanF-1082023-GSH011 |
|
| Corresponding Author |
Hui-Chun Xing, Chief Physician, MD, PhD, Professor, Center of Liver Diseases Division 3, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshun East Street, Chaoyang District, Beijing 100015, China. hchxing@sohu.com |
| Key Words |
Clinical efficacy; Liver-gut axis; Intestinal microbiota; Fecal microbiota transplantation; Chronic liver disease |
| Core Tip |
Fecal microbiota transplantation shows significant potential in treating chronic liver diseases by improving liver inflammation, biomarkers, lipid metabolism, and cognitive function. It works through the liver-gut axis, restoring intestinal microbiota balance. Despite promising results, challenges remain in donor selection, standard treatment protocols, and long-term safety. Ongoing clinical trials and further research are needed to refine protocols and establish standardized approaches for optimal efficacy and safety in managing chronic liver diseases. |
| Publish Date |
2025-07-24 07:47 |
| Citation |
<p>Ma L, Zhang MH, Xu YF, Hao YX, Niu XX, Li Y, Xing HC. Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease. <i>World J Gastroenterol</i> 2025; 31(28): 105089</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i28/105089.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i28.105089 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
